Get the latest delivered to your inbox
Privacy Policy

Now Reading

MedMira Rapid HIV Tests Donated to African Orphanage

MedMira Rapid HIV Tests Donated to African Orphanage

Published 08-19-04

Submitted by MedMira Inc.

HALIFAX - MedMira Inc. ("MedMira") (TSXVenture: MIR, NASDAQ:MMIRF), the market leader in rapid flow-through diagnostic technology, announced today that it has donated MiraWell™ Rapid HIV Tests to the Hopes and Dreams Team for use in Kenya at an orphanage where over 700 orphaned children have been given shelter from street life.

These rapid HIV tests enabled the medical clinic at the orphanage to screen each child residing at the site for HIV-infection (the virus that causes AIDS) and provide subsequent counseling and care.

The World Health Organization estimates that by 2010 there will be 43 million orphaned children living on the streets in Africa. The continent is currently known to be experiencing the worst AIDS epidemic in the world. It is estimated that some 750 people die each day of AIDS-related illnesses in Kenya alone, just a small portion of the 356 people dying each hour in the whole of Africa. Many children have been left homeless due to the loss of their parents from this devastating virus and many of these same children are also infected with HIV.

Hermes Chan, president and COO of MedMira says, "From the beginning, one of MedMira's key corporate objectives has been to establish ourselves in a significant role in improving global healthcare by providing those at greatest risk with a rapid, reliable method of virus detection. We are extremely proud to be able to help such a dedicated organization as the Hopes and Dreams team by providing them with our rapid HIV test. With our test, these children, who are at a high-risk for HIV-infection, have been tested in a setting where counseling and treatment is readily available." The rapid HIV tests traveled with the Hopes and Dreams Team on their trip to Africa in mid-July.

"The Hopes and Dreams Team is thrilled and thankful to be able to partner with MedMira in this critically important cause. These tests enabled us to determine the number of children infected with HIV, so that we can better manage their future health and life and provide protection for the other children." says Janine Maxwell, leader of the Hopes and Dreams team and former owner of Onyx Marketing Group, one of Canada's premier marketing agencies which she sold after returning from a trip to Kenya in 2003 in order to return and provide more assistance to these children by founding the Hopes and Dreams Team.

About MedMira

MedMira is the leading global manufacturer and marketer of in vitro flow-though rapid diagnostic tests for the clinical laboratory market. MedMira's tests provide reliable, rapid diagnosis in just 3 minutes for the detection of human antibodies in human serum, plasma or whole blood for diseases such as HIV. The United States FDA and the SFDA in the People's Republic of China have approved MedMira's Reveal™ G2 and MiraWell™ Rapid HIV Tests, respectively. For more information visit MedMira's website at www.medmira.com.

About Hopes and Dreams Team

The Hopes and Dreams Team was founded in 2003 by Janine Maxwell after a mission trip to Kenya in order to bring assistance to the orphaned children at the Mully Children's Family orphanage. A non-profit organization based in Ontario, Canada the Hopes and Dreams Team will continue to bring aid and services to over 700 orphaned children in this developing nation in Africa. More information can be found at www.hopesanddreamsteam.ca

This news release contains forward-looking statements, which involve risk and uncertainties and reflect the company's current expectation regarding future events. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement.

MedMira Inc.

MedMira Inc.

More from MedMira Inc.

Join today and get the latest delivered to your inbox